Histogenics Corp (NASDAQ:HSGX) Exploring Restructuring Alternatives ...
12/30/18
Histogenics Corp (NASDAQ:HSGX) Exploring Restructuring Alternatives Amidst Regulatory Hurdle for NeoCart FDA Headlines
Dec 30, 2018 | Business. Histogenics Corp (NASDAQ:HSGX) Exploring Restructuring Alternatives Amidst Regulatory Hurdle for NeoCart®. Upon reviewing ...
[more]- Feeds Categories:
